ArticleCureus2026
Eosinophilic Fasciitis With Overlap Connective Tissue Disease: A Diagnostic Challenge in Progressive Skin Fibrosis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eosinophilic fasciitis (EF) is a rare connective tissue disorder characterized by inflammation and fibrosis of the deep fascia and adjacent subcutaneous tissue. Because its clinical presentation may resemble systemic sclerosis (SSc), diagnosis can be delayed, particularly in patients with an established autoimmune disease. We report a 48-year-old woman with undifferentiated connective tissue disease (UCTD), inflammatory arthritis, and Sjögren's disease overlap syndrome who developed progressive skin thickening and loss of range of motion despite treatment for inflammatory arthritis. Although EF typically spares the fingers, this patient developed marked finger and hand tightness with inability to make a fist, resulting in an atypical sclerodactyly-like presentation that initially raised concern for SSc. However, the absence of Raynaud phenomenon, normal nailfold capillaroscopy, repeatedly negative SSc-specific antibodies, historical peripheral eosinophilia, and magnetic resonance imaging (MRI) demonstrating fascial thickening and enhancement supported a diagnosis of EF. A full-thickness skin-to-fascia biopsy was deferred because of prior glucocorticoid and immunosuppressive exposure and concern for impaired wound healing. The patient was treated with high-dose prednisone followed by a taper, together with mycophenolate and tocilizumab. Over the subsequent six months, she had improved hand closure, grip strength, and mobility, with stable skin findings at 18 months. This case highlights that EF can occasionally involve the fingers and mimic SSc, and that reviewing the overall clinical phenotype and historical laboratory data is important when the presentation is atypical.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.